GO:0030240 skeletal muscle thin filament assembly: Components, Assembly and Research Methods, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0030240 (skeletal muscle thin filament assembly) describes the aggregation, arrangement and bonding of proteins to form actin-based thin filaments of myofibrils in skeletal muscle.
Thin filament assembly requires coordinated actin polymerization, capping by tropomodulin at pointed ends, and association with tropomyosin and troponin complexes.
Thin filament length is developmentally regulated and changes during postnatal skeletal muscle development and aging in mice.
Defects in thin filament assembly and maintenance are linked to skeletal and cardiac myopathies, including nemaline myopathy and hypertrophic cardiomyopathy.
Key genes include ACTA1, TPM1, TPM2, TPM3, TNNT1, TNNT3, TNNI1, TNNI2, TNNC1, TNNC2, TMOD1, TMOD4, NEB, MYO18B, and LMOD3.
CRISPR-based knockout, point mutation, knock-in, and overexpression models enable causal testing of thin filament gene function in skeletal muscle cells and animal models.

Description

Skeletal muscle contraction depends on the precise assembly of sarcomeres, the basic contractile units of myofibrils. Within each sarcomere, thin filaments are actin-based structures that interact with myosin thick filaments to generate force. The Gene Ontology term GO:0030240, skeletal muscle thin filament assembly, captures the biological process by which proteins aggregate, arrange, and bond together to form these actin-based thin filaments in skeletal muscle. This process is essential for myofibrillogenesis and for the maintenance of muscle function throughout life. Understanding thin filament assembly is critical because mutations in thin filament proteins cause a range of human diseases, including congenital myopathies and cardiomyopathies. Moreover, thin filament length and composition are dynamically regulated during development and aging, influencing muscle performance. Researchers study this process using a combination of genetic, biochemical, and imaging approaches, and CRISPR-based models are increasingly used to dissect gene function.

skeletal muscle thin filament assembly At A Glance

GO ID GO:0030240
GO term skeletal muscle thin filament assembly
Ontology biological_process
Synonym None
Major function Assembly of actin-based thin filaments in skeletal muscle myofibrils
Key cellular location Sarcomere / myofibril
Key proteins Actin, tropomyosin, troponin, tropomodulin, nebulin, leiomodin
Related processes Myofibril assembly, sarcomere organization, muscle contraction

What Is GO:0030240?

GO:0030240 is defined as the aggregation, arrangement and bonding together of proteins to form the actin-based thin filaments of myofibrils in skeletal muscle. In simpler terms, it is the cellular process that builds the actin-containing filaments that slide against myosin to produce muscle contraction. This process involves actin polymerization, capping at filament ends, and the incorporation of regulatory proteins such as tropomyosin and troponin.

Why Is skeletal muscle thin filament assembly Important in Cell Biology?

Thin filament assembly is fundamental to skeletal muscle development and function. Disruption of this process leads to sarcomeric disorganization and muscle weakness, as seen in various myopathies. The precise regulation of thin filament length and composition is critical for optimal force generation, and alterations in thin filament proteins are associated with both skeletal and cardiac muscle diseases. Therefore, understanding the molecular mechanisms of thin filament assembly provides insights into muscle biology and potential therapeutic targets.
Essential for sarcomere formation and muscle contraction.
Mutations in thin filament genes cause congenital myopathies such as nemaline myopathy.
Thin filament length changes during postnatal development and aging, affecting muscle physiology.
Tropomodulin isoforms regulate pointed-end capping and are critical for thin filament stability.
Myo18b is essential for sarcomere assembly in fast skeletal muscle.
Thin filament assembly defects are linked to cardiomyopathies.
Understanding assembly mechanisms can inform regenerative medicine and muscle disease therapies.
CRISPR screens can identify novel regulators of thin filament assembly.

What Happens During skeletal muscle thin filament assembly?

Actin polymerization and nucleation
In simple terms: Actin monomers join together to form the core of the thin filament.
Thin filament assembly begins with the polymerization of actin monomers (G-actin) into filamentous actin (F-actin). This process is nucleated by actin-related proteins and requires ATP. In skeletal muscle, alpha-actin is the predominant isoform. The initial nucleation step is followed by elongation, where actin monomers are added to both ends, although the barbed end grows faster than the pointed end.
Pointed-end capping by tropomodulin
In simple terms: A protein called tropomodulin caps one end of the actin filament to control its length.
Tropomodulin isoforms (TMOD1-4) bind to the pointed end of actin filaments, preventing further addition or loss of actin monomers. This capping is crucial for maintaining thin filament length. Gokhin et al. showed that tropomodulin isoforms regulate pointed-end capping and skeletal muscle physiology, with different isoforms having distinct roles. The capping also anchors the filament to the Z-disk via interactions with nebulin or other proteins.
Tropomyosin and troponin association
In simple terms: Regulatory proteins attach along the actin filament to control contraction.
Tropomyosin dimers bind along the length of the actin filament, spanning seven actin monomers. Troponin, a complex of three subunits (TnT, TnI, TnC), associates with tropomyosin and regulates calcium-dependent contraction. The assembly of these regulatory proteins onto actin is essential for thin filament function. Mutations in tropomyosin and troponin genes are associated with myopathies.
Thin filament length regulation and anchoring
In simple terms: The length of the thin filament is carefully controlled and anchored in the sarcomere.
Thin filament length is regulated by a balance of capping and elongation factors. Nebulin, a giant protein, acts as a molecular ruler to specify thin filament length in skeletal muscle. Leiomodin (LMOD) promotes elongation by nucleating actin. The barbed end of the thin filament is anchored to the Z-disk, while the pointed end extends toward the center of the sarcomere. Alterations in thin filament length occur during postnatal development and aging.
Role of Myo18b in sarcomere assembly
In simple terms: Myo18b is a motor protein that helps organize the sarcomere.
Myo18b is an unconventional myosin that is essential for sarcomere assembly in fast skeletal muscle. Berger et al. demonstrated that loss of Myo18b leads to defective sarcomere formation and impaired muscle function. Myo18b may act by crosslinking actin filaments or by transporting components to the assembling sarcomere.

Key Genes Involved in GO:0030240 skeletal muscle thin filament assembly

The following genes encode proteins that play major roles in skeletal muscle thin filament assembly and regulation.
GeneMajor RoleResearch Relevance
ACTA1 Alpha-actin, main component of thin filaments Mutations cause nemaline myopathy and other actinopathies
TPM1 Tropomyosin 1, stabilizes actin filaments Mutations linked to cardiomyopathy and skeletal myopathy
TPM2 Tropomyosin 2, regulates actin-myosin interaction Mutations cause nemaline myopathy and arthrogryposis
TPM3 Tropomyosin 3, slow skeletal muscle isoform Mutations associated with nemaline myopathy
TNNT1 Slow skeletal troponin T Mutations cause nemaline myopathy (Amish type)
TNNT3 Fast skeletal troponin T Mutations linked to distal arthrogryposis
TNNI1 Slow skeletal troponin I Regulates calcium sensitivity; mutations in cardiomyopathy
TNNI2 Fast skeletal troponin I Mutations cause distal arthrogryposis
TNNC1 Slow skeletal/cardiac troponin C Calcium-binding subunit; mutations in cardiomyopathy
TNNC2 Fast skeletal troponin C Calcium-binding subunit; potential role in muscle function
TMOD1 Tropomodulin 1, pointed-end capping Regulates thin filament length in slow muscle
TMOD4 Tropomodulin 4, pointed-end capping Regulates thin filament length in fast muscle
NEB Nebulin, molecular ruler for thin filament length Mutations cause nemaline myopathy
MYO18B Unconventional myosin, sarcomere assembly Essential for fast skeletal muscle sarcomere assembly
LMOD3 Leiomodin 3, actin nucleation and elongation Mutations cause nemaline myopathy
ACTN2 Alpha-actinin 2, Z-disk crosslinking Anchors thin filaments at Z-disk
MYOZ2 Myozenin 2, Z-disk protein Links thin filaments to Z-disk
TCAP Telethonin, Z-disk protein Mutations in limb-girdle muscular dystrophy

How Is skeletal muscle thin filament assembly Regulated?

Thin filament assembly is regulated at multiple levels. Transcriptional regulation of actin and tropomyosin genes controls the availability of components. Post-translational modifications, such as phosphorylation of troponin and tropomyosin, modulate assembly and function. Tropomodulin isoforms are differentially expressed and regulated during development and aging, affecting thin filament length. Myo18b is regulated during muscle differentiation and is essential for sarcomere assembly. Additionally, signaling pathways such as mTOR may influence protein synthesis required for assembly, though direct evidence in this context is limited.

skeletal muscle thin filament assembly and Human Disease

GeneDisease / BiologyPotential Experimental Model
ACTA1Nemaline myopathyKnockout or point mutation in C2C12 myoblasts or mouse models
TPM2Nemaline myopathy, arthrogryposisKnock-in of patient mutations in mouse
TNNT1Nemaline myopathy (Amish type)Knockout mouse or patient-derived iPSCs
MYO18BSarcomere assembly defectsKnockout in zebrafish or mouse fast muscle
TMOD1Thin filament length regulationOverexpression or knockout in mouse muscle
Nemaline myopathy and thin filament mutations
Nemaline myopathy is a congenital muscle disorder characterized by the presence of nemaline rods in muscle fibers. Mutations in thin filament genes, including ACTA1, TPM2, TPM3, TNNT1, and NEB, are major causes of nemaline myopathy. These mutations disrupt thin filament assembly and function, leading to muscle weakness and hypotonia.
Cardiomyopathy and thin filament proteins
Mutations in thin filament regulatory proteins, such as TPM1, TNNT2, TNNI3, and TNNC1, are associated with hypertrophic cardiomyopathy and dilated cardiomyopathy. These mutations alter calcium sensitivity and force generation, highlighting the importance of thin filament assembly in cardiac function.
Thin filament length alterations in aging and disease
Changes in thin filament length occur during postnatal development and aging in mice, and may contribute to age-related muscle weakness. Gokhin et al. showed that thin filament length decreases with age, and this is accompanied by changes in tropomodulin expression. Such alterations may also be relevant in muscle wasting conditions.

From skeletal muscle thin filament assembly-Related Genes to Experimental Models

Research QuestionSuitable Model
What is the role of a candidate gene in thin filament assembly?CRISPR knockout in C2C12 myoblasts or primary myotubes
Does a specific point mutation cause thin filament disorganization?CRISPR point mutation knock-in in muscle cell lines
How does a disease-associated mutation affect protein function?Knock-in of mutant allele in mouse or iPSCs
Where does a protein localize during assembly?Tagged knock-in (e.g., GFP) in muscle cells
Does overexpression of a gene rescue assembly defects?Overexpression via lentiviral transduction in knockout cells
What are the global transcriptional changes during assembly?RNA-seq after CRISPR knockout of key genes

How to Study the skeletal muscle thin filament assembly Process

MethodWhat It MeasuresTypical Application
Fluorescence microscopyThin filament length, organization, protein localizationAssessing assembly defects in knockout cells
Electron microscopyUltrastructure of sarcomeres and thin filamentsConfirming sarcomere disorganization
Actin polymerization assayNucleation and elongation kineticsTesting effects of capping proteins
CRISPR screenIdentification of genes required for assemblyDiscovery of novel regulators
RNA-seqTranscriptional changes during assemblyEvaluating compensatory pathways
ProteomicsProtein composition of thin filamentsIdentifying novel thin filament components
ImmunoblottingProtein expression levelsValidating knockout or overexpression
Live cell imagingDynamic assembly processTracking filament growth in real time
Fluorescence microscopy and live imaging
Fluorescence microscopy, including confocal and super-resolution techniques, allows visualization of thin filament assembly in fixed and live muscle cells. Tagged proteins (e.g., GFP-actin, mCherry-tropomodulin) can be used to track dynamics. This method reveals filament length, organization, and localization.
Electron microscopy
Electron microscopy provides ultrastructural details of sarcomere assembly, including thin filament length and arrangement. It is often used to confirm defects in knockout or mutant models.
Biochemical assays for actin polymerization
In vitro actin polymerization assays using pyrene-labeled actin can measure nucleation and elongation rates in the presence of capping proteins like tropomodulin. These assays help dissect the biochemical mechanisms of assembly.
CRISPR screening and transcriptomics
Genome-wide CRISPR screens can identify novel regulators of thin filament assembly by selecting for cells with abnormal sarcomere formation. RNA-seq of knockout models reveals transcriptional changes that compensate for or result from assembly defects.

How CRISPR Can Be Used to Study GO:0030240 skeletal muscle thin filament assembly

Knockout

CRISPR knockout of thin filament genes (e.g., ACTA1, TMOD1, MYO18B) in muscle cell lines or animal models allows researchers to assess loss-of-function phenotypes. For example, knockout of Myo18b in mice results in defective sarcomere assembly in fast skeletal muscle. Knockout of tropomodulin isoforms alters thin filament length and muscle physiology.

Point Mutation

CRISPR point mutation knock-in can introduce disease-associated missense mutations into endogenous genes. This is particularly useful for modeling nemaline myopathy mutations in ACTA1 or TPM2, allowing study of mutant protein effects on thin filament assembly without overexpression artifacts.

Knock-in

Knock-in of reporter tags (e.g., GFP) or epitope tags into thin filament genes enables live imaging and biochemical purification of assembled complexes. Knock-in of human disease mutations into mouse models provides in vivo validation of pathogenicity.

Overexpression

CRISPR activation (CRISPRa) or lentiviral overexpression can be used to overexpress wild-type or mutant thin filament proteins. Overexpression of tropomodulin or leiomodin can elongate thin filaments, while overexpression of mutant actin may disrupt assembly.

How EDITGENE Supports skeletal muscle thin filament assembly Research

Researchers studying skeletal muscle thin filament assembly-related genes often need to determine whether a candidate gene is causally involved in the assembly process or whether its mutation contributes to disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell and animal models, enabling functional interrogation of thin filament genes.
Contact EDITGENE today to design your custom CRISPR model for skeletal muscle thin filament assembly research.

Related Products

Product name Cat.No. Species Gene ID
TTN Knockout HEK293 Cell Line EDJ-KQ2987 Human 7273 Details Get a Quote
ACTA1 Knockout HEK293 Cell Line EDJ-KQ3339 Human 58 Details Get a Quote
PROX1 Knockout HEK293 Cell Line EDJ-KQ3353 Human 5629 Details Get a Quote
ACTC1 Knockout HEK293 Cell Line EDJ-KQ3854 Human 70 Details Get a Quote
TCAP Knockout HEK293 Cell Line EDJ-KQ6286 Human 8557 Details Get a Quote
LMOD3 Knockout HEK293 Cell Line EDJ-KQ14092 Human 56203 Details Get a Quote
ACTC1 Knockout HeLa Cell Line EDJ-KQ26043 Human 70 Details Get a Quote
ACTA1 Knockout HeLa Cell Line EDJ-KQ52540 Human 58 Details Get a Quote
PROX1 Knockout HeLa Cell Line EDJ-KQ54225 Human 5629 Details Get a Quote
TTN Knockout HeLa Cell Line EDJ-KQ54702 Human 7273 Details Get a Quote
TCAP Knockout HeLa Cell Line EDJ-KQ54940 Human 8557 Details Get a Quote
LMOD3 Knockout HeLa Cell Line EDJ-KQ56720 Human 56203 Details Get a Quote
ACTA1 Knockout A-549 Cell Line EDJ-KQ61022 Human 58 Details Get a Quote
ACTC1 Knockout A-549 Cell Line EDJ-KQ61023 Human 70 Details Get a Quote
PROX1 Knockout A-549 Cell Line EDJ-KQ62719 Human 5629 Details Get a Quote
Displaying Records 1 To 15 Of 25 Records

Frequently Asked Questions About skeletal muscle thin filament assembly

GO:0030240 is the Gene Ontology term for skeletal muscle thin filament assembly, the process of forming actin-based thin filaments in skeletal muscle myofibrils.
Key genes include ACTA1, TPM1, TPM2, TPM3, TNNT1, TNNT3, TNNI1, TNNI2, TNNC1, TNNC2, TMOD1, TMOD4, NEB, MYO18B, and LMOD3.
Thin filament length is regulated by capping proteins like tropomodulin at the pointed end and by nebulin, which acts as a molecular ruler.
Defects are linked to nemaline myopathy, hypertrophic cardiomyopathy, and other congenital myopathies.
Tropomodulin caps the pointed end of actin filaments, controlling filament length and stability.
Myo18b is essential for sarcomere assembly in fast skeletal muscle, likely by organizing actin filaments.
Yes, CRISPR knockout, point mutation, and knock-in models enable functional studies of thin filament genes in muscle cells and animals.
Common methods include fluorescence microscopy, electron microscopy, actin polymerization assays, and CRISPR screens.
Thin filament length decreases during aging in mice, which may contribute to age-related muscle weakness.
Thin filaments are primarily composed of actin and associated regulatory proteins, while thick filaments are composed of myosin.

Conclusion

GO:0030240 skeletal muscle thin filament assembly is a fundamental biological process required for muscle contraction and sarcomere integrity. The coordinated assembly of actin, tropomyosin, troponin, and capping proteins ensures proper filament length and function. Disruption of this process leads to severe muscle diseases, underscoring its clinical relevance. Advances in CRISPR-based models and imaging techniques continue to unravel the molecular mechanisms of thin filament assembly, offering potential targets for therapeutic intervention.

References

  1. 1. Gregorio CC. 1997. Models of thin filament assembly in cardiac and skeletal muscle.. Cell Struct Funct 22(1):191-5 PMID: 9113406
  2. 2. Gokhin DS et al.. 2010. Tropomodulin isoforms regulate thin filament pointed-end capping and skeletal muscle physiology.. J Cell Biol 189(1):95-109 PMID: 20368620
  3. 3. Gokhin DS et al.. 2014. Alterations in thin filament length during postnatal skeletal muscle development and aging in mice.. Front Physiol 5:375 PMID: 25324783
  4. 4. Henderson CA et al.. 2017. Overview of the Muscle Cytoskeleton.. Compr Physiol 7(3):891-944 PMID: 28640448
  5. 5. Berger J et al.. 2017. Myo18b is essential for sarcomere assembly in fast skeletal muscle.. Hum Mol Genet 26(6):1146-1156 PMID: 28104788
  6. 6. Ojima K. 2019. Myosin: Formation and maintenance of thick filaments.. Anim Sci J 90(7):801-807 PMID: 31134719
  7. 7. Prill K et al.. 2020. Assembly and Maintenance of Sarcomere Thin Filaments and Associated Diseases.. Int J Mol Sci 21(2) PMID: 31952119
  8. 8. Vandenboom R. 2016. Modulation of Skeletal Muscle Contraction by Myosin Phosphorylation.. Compr Physiol 7(1):171-212 PMID: 28135003
Contact Us
*
*
*
*
How did you hear about us: